Literature DB >> 30037983

An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect.

Yasir H Qureshi1, Vivek M Patel1, Diego E Berman1,2, Milankumar J Kothiya1, Jessica L Neufeld1, Badri Vardarajan1,3, Min Tang1,3, Dolly Reyes-Dumeyer1, Rafael Lantigua4, Martin Medrano5, Ivonne J Jiménez-Velázquez6, Scott A Small7,8,2, Christiane Reitz7,3,8,9.   

Abstract

In a whole-exome sequencing study of multiplex Alzheimer's disease (AD) families, we investigated three neuronal ceroid lipofuscinosis genes that have been linked to retromer, an intracellular trafficking pathway associated with AD: ceroid lipofuscinosis 3 (CLN3), ceroid lipofuscinosis 5 (CLN5), and cathepsin D (CTSD). We identified a missense variant in CLN5 c.A959G (p.Asn320Ser) that segregated with AD. We find that this variant causes glycosylation defects in the expressed protein, which causes it to be retained in the endoplasmic reticulum with reduced delivery to the endolysosomal compartment, CLN5's normal cellular location. The AD-associated CLN5 variant is shown here to reduce the normal processing of cathepsin D and to decrease levels of full-length amyloid precursor protein (APP), suggestive of a defect in retromer-dependent trafficking.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Alzheimer's disease; CLN5; NCL; endosomes; retromer

Mesh:

Substances:

Year:  2018        PMID: 30037983      PMCID: PMC6168984          DOI: 10.1128/MCB.00011-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses.

Authors:  Ruth E Williams; Sara E Mole
Journal:  Neurology       Date:  2012-07-10       Impact factor: 9.910

2.  Microglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotype.

Authors:  A M Floden; C K Combs
Journal:  J Neurosci Methods       Date:  2007-05-03       Impact factor: 2.390

3.  TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.

Authors:  Tyler K Ulland; Wilbur M Song; Stanley Ching-Cheng Huang; Jason D Ulrich; Alexey Sergushichev; Wandy L Beatty; Alexander A Loboda; Yingyue Zhou; Nigel J Cairns; Amal Kambal; Ekaterina Loginicheva; Susan Gilfillan; Marina Cella; Herbert W Virgin; Emil R Unanue; Yaming Wang; Maxim N Artyomov; David M Holtzman; Marco Colonna
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

4.  The neuronal ceroid lipofuscinosis protein CLN5: new insights into cellular maturation, transport, and consequences of mutations.

Authors:  Mia-Lisa Schmiedt; Carlos Bessa; Claudia Heine; Maria Gil Ribeiro; Anu Jalanko; Aija Kyttälä
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

5.  The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain.

Authors:  Ville Holmberg; Anu Jalanko; Juha Isosomppi; Anna-Liisa Fabritius; Leena Peltonen; Outi Kopra
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

6.  VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.

Authors:  Emiko Miura; Takafumi Hasegawa; Masatoshi Konno; Mari Suzuki; Naoto Sugeno; Nobuhiro Fujikake; Sven Geisler; Mitsuaki Tabuchi; Ryuji Oshima; Akio Kikuchi; Toru Baba; Keiji Wada; Yoshitaka Nagai; Atsushi Takeda; Masashi Aoki
Journal:  Neurobiol Dis       Date:  2014-08-06       Impact factor: 5.996

Review 7.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

8.  Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship.

Authors:  Anne-Hélène Lebrun; Stephan Storch; Franz Rüschendorf; Mia-Lisa Schmiedt; Aija Kyttälä; Sara E Mole; Claudia Kitzmüller; Kathrin Saar; Leena D Mewasingh; Volker Boda; Alfried Kohlschütter; Kurt Ullrich; Thomas Braulke; Angela Schulz
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

Review 9.  Retromer: a master conductor of endosome sorting.

Authors:  Christopher Burd; Peter J Cullen
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-02-01       Impact factor: 10.005

Review 10.  A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.

Authors:  Jérôme Stirnemann; Nadia Belmatoug; Fabrice Camou; Christine Serratrice; Roseline Froissart; Catherine Caillaud; Thierry Levade; Leonardo Astudillo; Jacques Serratrice; Anaïs Brassier; Christian Rose; Thierry Billette de Villemeur; Marc G Berger
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

View more
  17 in total

1.  Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Olaia Martínez-Iglesias; Lola Corzo; Natalia Cacabelos; Rocío Pego; Juan C Carril
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

Review 3.  Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Authors:  Yasir H Qureshi; Penelope Baez; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2020-09-14       Impact factor: 4.272

Review 4.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

Review 5.  Cathepsin D-Managing the Delicate Balance.

Authors:  Olja Mijanovic; Anastasiia I Petushkova; Ana Brankovic; Boris Turk; Anna B Solovieva; Angelina I Nikitkina; Sergey Bolevich; Peter S Timashev; Alessandro Parodi; Andrey A Zamyatnin
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

6.  Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40.

Authors:  Caitlin N Suire; Samer O Abdul-Hay; Tomoko Sahara; Dongcheul Kang; Monica K Brizuela; Paul Saftig; Dennis W Dickson; Terrone L Rosenberry; Malcolm A Leissring
Journal:  Alzheimers Res Ther       Date:  2020-07-06       Impact factor: 6.982

Review 7.  Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum.

Authors:  Meagan D McLaren; Sabateeshan Mathavarajah; Robert J Huber
Journal:  Cells       Date:  2019-02-02       Impact factor: 7.666

Review 8.  Molecular networking in the neuronal ceroid lipofuscinoses: insights from mammalian models and the social amoeba Dictyostelium discoideum.

Authors:  Robert J Huber
Journal:  J Biomed Sci       Date:  2020-05-20       Impact factor: 8.410

9.  Retromer regulates the lysosomal clearance of MAPT/tau.

Authors:  Julian M Carosi; Leanne K Hein; Mark van den Hurk; Robert Adams; Bridget Milky; Sanjna Singh; Cedric Bardy; Donna Denton; Sharad Kumar; Timothy J Sargeant
Journal:  Autophagy       Date:  2020-09-22       Impact factor: 16.016

10.  Neuronal Ceroid Lipofuscinoses: Connecting Calcium Signalling through Calmodulin.

Authors:  Sabateeshan Mathavarajah; Danton H O'Day; Robert J Huber
Journal:  Cells       Date:  2018-10-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.